Mu Chunlong, Yang Qingyuan, Zhang Yina, Zhou Yonghui, Zhang Jixi, Martin Darren P, Xia Pingan, Cui Baoan
College of Animal Science and Veterinary Medicine, Henan Agricultural University, No. 95 Wenhua Road, Zhengzhou, China.
Virus Genes. 2012 Dec;45(3):463-73. doi: 10.1007/s11262-012-0789-7. Epub 2012 Jul 29.
Porcine circovirus type 2 (PCV2) infection causes postweaning multisystemic wasting syndrome and porcine circovirus-associated diseases in many regions. A total of 77 sequences, including 31 sampled from Henan province of China, were retrieved from GenBank and subjected to amino acid variation and phylogenetic analyses. The two PCV genotypes prevailing in Henan were PCV-2a and PCV-2b with PCV-2b accounting for 93.5 % (29/31) of the Henan isolates. The 31 Henan isolates all shared between 92.7 and 100 % sequence similarity. Amino acid variation analysis of the capsid protein revealed that Henan PCV2 strains tended to accumulate more substitutions within epitopic regions-a substitution pattern consistent with host immune system-mediated selection of virus immune escape variants. The analysed PCV sequences carry evidence of at least six unique recombination events. Selective pressure analysis of the relative recombination-free ORF2 sequences of these viruses revealed evidence of sites that are likely evolving in response to host-driven immune pressures-a finding that coupled with information on the prevalent diversity in Henan PCV2 isolates of known immunoreactive genomic loci will aid in future studies aiming to assess the evolutionary responses of PCV2 in China to the widespread deployment of anti-PCV vaccines in the country.
猪圆环病毒2型(PCV2)感染在许多地区引发断奶后多系统消耗综合征和猪圆环病毒相关疾病。从GenBank中检索到总共77个序列,其中31个来自中国河南省,对其进行氨基酸变异和系统发育分析。在河南流行的两种PCV基因型是PCV - 2a和PCV - 2b,其中PCV - 2b占河南分离株的93.5%(29/31)。31株河南分离株的序列相似性均在92.7%至100%之间。衣壳蛋白的氨基酸变异分析表明,河南PCV2毒株倾向于在表位区域积累更多替换——这种替换模式与宿主免疫系统介导的病毒免疫逃逸变体选择一致。分析的PCV序列显示至少有六个独特的重组事件。对这些病毒相对无重组的ORF2序列进行选择性压力分析,发现了可能因宿主驱动的免疫压力而进化的位点——这一发现与河南已知免疫反应性基因组位点的PCV2分离株中普遍存在的多样性信息相结合,将有助于未来旨在评估中国PCV2对该国广泛使用的抗PCV疫苗的进化反应的研究。